Chimera Peptides: A Novel Therapeutic Frontier
A new clinical arena concerns hybrid chains. Such engineered compounds integrate segments of different peptide sources, facilitating the development of distinct pharmacological properties. This strategy provides a significant path for create targeted therapies possessing improved potency or minim